PT1062341E - Alergénios recombinantes mutantes - Google Patents

Alergénios recombinantes mutantes Download PDF

Info

Publication number
PT1062341E
PT1062341E PT99907345T PT99907345T PT1062341E PT 1062341 E PT1062341 E PT 1062341E PT 99907345 T PT99907345 T PT 99907345T PT 99907345 T PT99907345 T PT 99907345T PT 1062341 E PT1062341 E PT 1062341E
Authority
PT
Portugal
Prior art keywords
allergens
recombinant allergens
mutant recombinant
disclosed
recombinant
Prior art date
Application number
PT99907345T
Other languages
English (en)
Inventor
Hans-Henrik Ipsen
Michael Dho Spangfort
Joergen Nedergaard Larsen
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8092687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1062341(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alk Abello As filed Critical Alk Abello As
Publication of PT1062341E publication Critical patent/PT1062341E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT99907345T 1998-03-16 1999-03-16 Alergénios recombinantes mutantes PT1062341E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK36498 1998-03-16

Publications (1)

Publication Number Publication Date
PT1062341E true PT1062341E (pt) 2008-12-24

Family

ID=8092687

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99907345T PT1062341E (pt) 1998-03-16 1999-03-16 Alergénios recombinantes mutantes

Country Status (20)

Country Link
US (1) US20040091500A1 (pt)
EP (1) EP1062341B1 (pt)
JP (1) JP2002506648A (pt)
KR (1) KR20010041918A (pt)
CN (1) CN1332029C (pt)
AT (1) ATE408690T1 (pt)
AU (1) AU749749B2 (pt)
CA (1) CA2323687C (pt)
DE (1) DE69939584D1 (pt)
DK (1) DK1062341T3 (pt)
ES (1) ES2313776T3 (pt)
HK (1) HK1033591A1 (pt)
HU (1) HUP0101464A3 (pt)
IL (2) IL138339A0 (pt)
NO (1) NO328354B1 (pt)
NZ (1) NZ506665A (pt)
PL (1) PL194804B1 (pt)
PT (1) PT1062341E (pt)
WO (1) WO1999047680A1 (pt)
ZA (1) ZA200004819B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2236611A1 (en) * 2000-04-28 2010-10-06 Novozymes A/S Lipolytic enzyme variant
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.
IT1318690B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti dell'allergene maggiore par j 2 di parietaria judaica.
EP1340085B1 (en) * 2000-10-17 2008-07-30 Besst-Test Aps Assay for directly detecting a biological cell in a body fluid sample
PL214225B1 (pl) * 2000-11-16 2013-07-31 Alk Abello As Zrekombinowany alergen, zastosowanie zrekombinowanego alergenu, kompozycja farmaceutyczna, sposób przygotowania kompozycji farmaceutycznej, sposób przygotowania zrekombinowanego alergenu, sekwencja DNA kodujaca zrekombinowany alergen, wektor ekspresyjny, komórka gospodarza oraz sposób produkcji zrekombinowanego zmutowanego alergenu
EP1219300B1 (en) * 2000-12-28 2006-12-06 BIOMAY Produktions- und Handels- Aktiengesellschaft Treatment of allergies
US20030039660A1 (en) * 2001-03-02 2003-02-27 The Rockefeller University Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
WO2003031981A2 (en) * 2001-10-05 2003-04-17 Novozymes A/S Kit for predicting binding of a specific antibody to a potential immunogen and method of screening
PL212139B1 (pl) * 2002-05-16 2012-08-31 Alk Abello As Zrekombinowany alergen, zastosowanie zrekombinowanego alergenu, kompozycja zawierająca dwa lub więcej wariantów zrekombinowanych zmutowanych alergenów, zastosowanie takiej kompozycji, kompozycja farmaceutyczna zawierająca zrekombinowany alergen lub wymienioną kompozycję, zastosowanie zrekombinowanego alergenu, kompozycji lub kompozycji farmaceutycznej, sposób przygotowania kompozycji farmaceutycznej, sposób przygotowania zrekombinowanego alergenu, sposób przygotowania biblioteki zrekombinowanego alergenu, sekwencja DNA kodująca zrekombinowany alergen, wektor ekspresyjny obejmujący wymienione DNA, komórka gospodarza zawierająca taki wektor ekspresyjny, sposób produkcji zrekombinowanego mutanta alergenu, oraz oznaczenie diagnostyczne do oceny odpowiedniości, bezpieczeństwa lub wyniku terapii
JP2006520184A (ja) * 2002-11-01 2006-09-07 アルカベロ アクチェセルスカプ 組換えタンパク質変種
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
MXPA05009079A (es) 2003-02-28 2006-05-19 Alk Abello As Forma de dosificacion que tiene una matriz de sacarido.
BRPI0417264A (pt) 2003-12-19 2007-03-06 Alk Abello As processos para a preparação de uma batelada de um ingrediente farmacêutico ativo, um recipiente compreendendo criogránulos de um produto alérgeno, e um criogránulo de um produto alérgeno
JP2009510136A (ja) 2005-10-04 2009-03-12 アルク−アベッロ エイ／エス 固体ワクチン製剤
ITMI20052517A1 (it) * 2005-12-29 2007-06-30 Lofarma Spa Varianbtio ipoallergeniche dell'allergene maggiore bet v 1 di polline di betula verrucosa
EP2010645A4 (en) * 2006-04-20 2009-05-06 Univ Singapore RECOMBINANT LACTOBACILLUS AND USE THEREOF
WO2008100598A2 (en) * 2007-02-15 2008-08-21 Mannkind Corporation A method for enhancing t cell response
WO2008116936A1 (en) 2007-03-28 2008-10-02 Alk-Abelló A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
EP2028188A1 (en) * 2007-08-21 2009-02-25 Biomay AG Hypoallergenic molecules
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
ES2606550T3 (es) 2009-06-19 2017-03-24 Alk-Abelló S.A. Nueva manera de administrar alérgeno en inmunoterapia específica con alérgenos
CN102584966A (zh) * 2011-11-14 2012-07-18 广州医学院第二附属医院 一种重组花生过敏原与突变体及其制备方法和应用
CN102617719A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组大米过敏原与突变体及其制备方法和应用
CN102603879A (zh) * 2012-03-30 2012-07-25 广州医学院第二附属医院 一种重组大豆过敏原与突变体及其制备方法和应用
CN102690340A (zh) * 2012-03-30 2012-09-26 广州医学院第二附属医院 一种重组巴西坚果过敏原与突变体及其制备方法和应用
CN102617715A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组真菌主要过敏原与突变体及其制备方法和应用
CN102675439A (zh) * 2012-03-31 2012-09-19 广州医学院第二附属医院 一种重组黑麦草花粉过敏原与突变体的制备方法和应用
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
CN111187606B (zh) * 2020-02-25 2022-06-14 江苏海洋大学 一种用于海水基可循环清洁压裂液的表面活性剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804201A (en) * 1996-03-11 1998-09-08 The Rockefeller University Immunomodulatory peptides of vespid antigen 5
EP1051494B1 (en) * 1998-01-31 2009-04-29 The University of Arkansas Methods and reagents for decreasing allergic reactions
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.

Also Published As

Publication number Publication date
HUP0101464A3 (en) 2004-10-28
JP2002506648A (ja) 2002-03-05
NO328354B1 (no) 2010-02-01
NO20004614L (no) 2000-10-26
IL138339A0 (en) 2001-10-31
EP1062341B1 (en) 2008-09-17
HK1033591A1 (en) 2001-09-07
CA2323687C (en) 2008-11-25
DK1062341T3 (da) 2008-11-03
PL343029A1 (en) 2001-07-30
AU749749B2 (en) 2002-07-04
WO1999047680A1 (en) 1999-09-23
AU2714799A (en) 1999-10-11
CN1293710A (zh) 2001-05-02
ES2313776T3 (es) 2009-03-01
IL138339A (en) 2009-06-15
CA2323687A1 (en) 1999-09-23
PL194804B1 (pl) 2007-07-31
US20040091500A1 (en) 2004-05-13
ATE408690T1 (de) 2008-10-15
CN1332029C (zh) 2007-08-15
HUP0101464A2 (hu) 2001-08-28
NO20004614D0 (no) 2000-09-15
NZ506665A (en) 2003-08-29
DE69939584D1 (de) 2008-10-30
EP1062341A1 (en) 2000-12-27
KR20010041918A (ko) 2001-05-25
ZA200004819B (en) 2001-05-30

Similar Documents

Publication Publication Date Title
HK1033591A1 (en) Mutant recombinant allergens
AU2350502A (en) Novel mutant allergens
WO2003020889A3 (en) Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
MXPA04002593A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
MXPA03011985A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
CA2000786A1 (en) 3-piperidinyl-1,2-benzisoxazoles
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
HUP0302965A2 (hu) Vakcina
MX9801159A (es) Metodos de reduccion o para mantener los niveles reducidos de lipidos en la sangre usando composiciones de proteina ob.
BG102818A (en) D-manitol and method for its preparation
AU3227700A (en) Skin sanitizing compositions
IL145795A0 (en) Mutant human cd80 and compositions for and methods of making and using the same
WO2006110760A3 (en) Compositions and methods for the diagnosis and treatment of tumor
MX9708426A (es) Polipeptido hk2 de variante estable.
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
ATE284708T1 (de) T-zellimpfung zur behandlung von multiple sclerosis
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
MXPA04001986A (es) Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
WO2000015797A3 (en) Compositions and methods for the treatment of immune related diseases
IL153576A0 (en) Dna vaccines encoding hiv accessory proteins
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
WO2001016319A3 (en) Compositions and methods for the treatment of immune related diseases
WO2004004649A3 (en) Compositions and methods for the treatment of immune related diseases
WO1999015160A3 (en) Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies